Everest Medicines Acquires Exclusive Rights to VIS-101 for Eye Disorders Everest Medicines has acquired an exclusive license to develop, manufacture, and commercialize VIS-101, a novel bif…
China Achieves Near-Perfect Lithography with Cryo-ET Process The Cryo-ET process has enabled Chinese researchers to pinpoint the source of…
NMC Clarifies on Medical Faculty Regulations 2025 The National Medical Commission (NMC) has provided clarity on the Medical Institutions (…
Alzheimer's Drug Approved by Health Canada Lecanemab aims to slow early stages of the disease by targeting plaques in the brain. He…
GSK and Empirico Collaborate on Oligonucleotide Candidate GSK plc and Empirico Inc. have entered into a worldwide exclusive license agreem…
Sleep Scientists’ Tips for a Healthier Time Change Circadian researchers explain why a single hour can rattle your body, and the simple st…
Enzo Trulli to Make LMP2 Debut with Algarve Pro Enzo Trulli, son of former Formula 1 racer Jarno Trulli, will make his LMP2 race debut wit…
Afterglow Update: Fine-Tuning Post-Apocalyptic Rhythm Afterglow has released version 0.2.17 on Google Play and TestFlight, featuring impro…
Implementing Photobiomodulation for Dry AMD Dry age-related macular degeneration progresses slowly but relentlessly, resulting in meaningf…
Wizz Air Revives $580 Pass and Tests Business Class European budget airline Wizz Air has relaunched its popular ‘All You Can Fly’ membersh…
China Achieves Near-Perfect Lithography with Cryo-ET Process Chinese researchers have made a significant breakthrough in chip manufacturin…